Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris

Withdrawn before enrolling · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Postinflammatory Hyperpigmentation

In brief

The goal of this study is to determine if topical tranexamic acid is capable of decreasing the pigment of the dark spots left from acne bumps. The first line medication used for this often is not tolerated well by patients, and topical tranexamic acid has minimal reported side effects thus far.

Key facts

Study ID

NCT03361345

Run by

Wayne State University

People needed

0

Starts

2018-11-01

Expected to finish

2022-01-09

Last updated by the study team

2023-05-16

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18 to 65
• Patients with bilateral involvement of facial postinflammatory hyperpigmentation due to acne vulgaris.

You may not qualify if…

• Pregnant patients or patients planning to become pregnant during the time of the study.
• Patients with a history of use of hydroquinone, kojic acid, tretinoin, adapalene, tazarotene or azaleic acid in the previous 3 months.

Where it is running

• WSUPG Dermatology — Dearborn, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.